VenoPlus 8 Review (2026): MenaQ7® Vitamin K2, RedNite® Beetroot, Pomella® Pomegranate, L-Citrulline & Magnesium — Simple Promise's 10-Ingredient Cardiovascular Health Powder Honestly Examined
Cardiovascular disease remains the leading cause of death globally, accounting for approximately 18 million deaths annually. In the United States, an estimated 121.5 million adults have some form of cardiovascular disease — and millions more have risk factors (hypertension, elevated LDL, poor circulation) that physician-directed lifestyle management alone insufficiently addresses. The dietary supplement market for heart health has responded with thousands of products — but most combine generic ingredients at modest doses without the three distinguishing markers of a credible cardiovascular formula: patented, standardised ingredient forms; published clinical evidence at the formula's actual doses; and formulation transparency.
VenoPlus 8™ by Simple Promise ("We Follow the Science") makes a credible claim in this competitive space by combining three patented branded ingredients — MenaQ7® (the only clinically studied Vitamin K2 MK-7 form for cardiovascular health), RedNite® (patented beetroot concentrate extracted within 24 hours of harvest), and Pomella® (patented pomegranate extract standardised for urolithins) — alongside L-Citrulline, L-Arginine, L-Taurine, Magnesium, Hesperidin, Vitamin C, and Grape Seed Extract, in a daily powder (Green Apple flavour, 5.4g scoop). Free US shipping. 365-day money-back guarantee (empty jars accepted). ClickBank. Here is the complete honest review.
What Is VenoPlus 8?
VenoPlus 8™ is a cardiovascular health powder (5.71 oz / 162g, ~30 servings) by Simple Promise. 1 scoop (5.4g) daily in 10 fl. oz. water with a meal. 10 ingredients including patented MenaQ7® K2, RedNite® beetroot, Pomella® pomegranate, L-Citrulline, L-Arginine, L-Taurine, Magnesium, Hesperidin, Vitamin C, Grape Seed Extract. Vegetarian, gluten-free, non-GMO. cGMP USA. ClickBank. 365-day guarantee. Free US shipping. 3 free bonus guides.
→ Check Current Price & DiscountOur Quick Verdict — Editorial Score: 8.4/10
VenoPlus 8: The Most Credibly Formulated Cardiovascular Supplement Reviewed on This Site — Three Patented Branded Ingredients With Published Clinical Evidence (MenaQ7®, RedNite®, Pomella®), Dual Nitric Oxide Pathway Design (L-Citrulline + L-Arginine + RedNite®), a Comprehensive Antioxidant-Vasodilatory Stack, and the Most Generous Guarantee in This Entire Review Batch (365 Days, Empty Jars)
What We Like
- MenaQ7® — the only Vitamin K2 (as MK-7) form with published clinical trial evidence specifically for cardiovascular endpoints; the published 3-year, double-blind, placebo-controlled trial (Thrombosis and Haemostasis, 2015) in 244 healthy postmenopausal women confirmed MenaQ7® supplementation significantly slowed coronary calcification (CAC progression) and significantly improved arterial flexibility (distensibility) vs. placebo — these are direct, published cardiovascular outcome measures; MenaQ7® works by activating Matrix Gla Protein (MGP), which prevents calcium from depositing in arterial walls; arterial calcification is a published independent risk factor for cardiovascular events, separate from LDL cholesterol; the inclusion of MenaQ7® rather than generic Vitamin K2 is the formula's most important quality signal
- RedNite® — a patented beetroot concentrate extracted within 24 hours of harvest to preserve antioxidant and nitrate potency; the manufacturer (ESM Technologies/Enovate Biolife) claims RedNite® increases nitric oxide levels more effectively than whole beets due to its concentrated, rapid-extraction format; beetroot nitrates' NO-boosting effect is one of the most published natural cardiovascular mechanisms — the original published study in Hypertension (2010) showed a 10.4mmHg systolic blood pressure reduction from beetroot juice; the patented extraction preserving peak nitrate and betacyanin content is a genuine product quality differentiator
- Pomella® — a patented pomegranate extract (by Verdure Sciences) standardised for punicosides and urolithins; published clinical research confirmed Pomella® significantly increased plasma antioxidant capacity in a published human study; urolithins (the gut-metabolised bioactive compounds from pomegranate ellagitannins) specifically published for improving arterial flexibility and endothelial function; Pomella®'s patented standardisation ensures consistent urolithin precursor content vs. standard pomegranate extracts
- Triple nitric oxide pathway: L-Citrulline (converts to L-Arginine in kidneys → eNOS substrate → NO) + L-Arginine (direct eNOS substrate → NO) + RedNite® (dietary nitrate → nitrite → NO, independent of eNOS); this triple-pathway NO design is the formula's most sophisticated cardiovascular mechanism; endothelial NO is the master regulator of vascular tone — it causes smooth muscle relaxation in blood vessel walls, reducing arterial stiffness and blood pressure; NO deficiency is a published central driver of hypertension and atherosclerosis; the three separate NO pathways ensure robust NO availability across diverse individuals with variable eNOS function
- Magnesium — published essential cardiovascular co-factor; meta-analysis of 10+ studies confirmed magnesium supplementation significantly reduces systolic and diastolic blood pressure; NHANES data confirms 45% of Americans consume below the RDA; magnesium is an NMDA receptor antagonist (blocking vasoconstrictive calcium-channel activation) and supports endothelial NO synthase activity
- Hesperidin (citrus bioflavonoid) — published anti-inflammatory and endothelial protective effects; meta-analysis confirmed Hesperidin supplementation significantly reduces LDL cholesterol, blood pressure, and inflammatory markers; inhibits NF-κB inflammatory pathway relevant to atherosclerotic plaque development; improves capillary permeability and venous tone (particularly relevant for venous insufficiency and leg circulation)
- L-Taurine — published as an antioxidant in vascular tissue, protecting endothelium from oxidative damage; published clinical study confirmed L-Taurine supplementation significantly improved flow-mediated dilation (endothelial function measure) in type 2 diabetics; also published for mild blood pressure reduction and anti-arrhythmic effects
- Vitamin C — essential for endothelial function; published to improve flow-mediated dilation (a standard measure of arterial health); required for collagen synthesis in vessel walls; published antioxidant protection of LDL cholesterol from oxidation (a key step in atherosclerotic plaque formation)
- Grape Seed Extract — OPC (oligomeric proanthocyanidin) antioxidants; published meta-analysis confirmed grape seed extract significantly reduces systolic blood pressure and heart rate; OPCs protect arterial walls from oxidative damage and improve endothelial function; one of the most published botanical antioxidants for cardiovascular health
- Powder format — important cardiovascular advantage over capsules; powder mixes immediately dissolve in water, enabling the nitrate (RedNite®) and amino acid (L-Citrulline, L-Arginine, L-Taurine) components to enter the bloodstream more rapidly and at higher plasma peaks than encapsulated forms; for cardiovascular applications where timing of NO production matters (pre-activity use), powder delivery is pharmacokinetically superior
- Vegetarian, gluten-free, lactose-free, nut-free, GMO-free, antibiotic-free — the most comprehensive dietary certification set in this review batch
- cGMP-certified, made in USA from finest domestic and foreign ingredients
- 365-day money-back guarantee (even empty jars) — the most generous guarantee reviewed on this site across all sessions; full year evaluation period covers the arterial remodelling timeline (MenaQ7®'s arterial calcification effects published at 3 years; blood pressure effects published at 8+ weeks)
- Free US shipping on all orders; 3 free digital bonus guides included
- No auto-billing; one-time payment
What to Know Going In
- Individual ingredient doses not disclosed — the landing page names all 10 ingredients and their mechanisms but does not disclose exact per-serving amounts for each ingredient; this prevents direct comparison of each ingredient to its published clinical effective dose
- Grape Seed Extract — mild antiplatelet activity; caution with anticoagulant medications
- Results timeline varies by mechanism — NO-mediated blood pressure effects: 2–4 weeks; arterial stiffness improvement from MenaQ7® and Pomella®: months to years; the 365-day guarantee appropriately covers the full range
8.4
★★★★☆
Strongly Recommended — With Physician Awareness
Best fit: adults 45+ with cardiovascular risk factors (mild-to-moderate hypertension in normal range, poor circulation, arterial stiffness concerns) who want a premium multi-mechanism cardiovascular supplement with published patented ingredients and physician-directed management
📋 In This Review
- Cardiovascular Health — Why This Category Needs Higher Standards
- The 3 Patented Branded Ingredients — MenaQ7®, RedNite®, Pomella®
- The Triple Nitric Oxide Pathway Design
- All 10 Ingredients — Evidence Deep Dive
- MenaQ7® — The Formula's Most Clinically Published Ingredient
- Drug Interactions & Safety
- How to Use VenoPlus 8
- What Users Report
- The 3 Free Digital Bonuses
- The 365-Day Guarantee
- Who Should Use VenoPlus 8
- Pricing & Packages
- Final Verdict
- FAQ
10
Active ingredients including 3 patented branded forms (MenaQ7®, RedNite®, Pomella®) — the highest number of patented branded ingredients in a single supplement reviewed on this site to date
365
Day money-back guarantee (even empty jars) — the most generous guarantee on this site; full year evaluation period covers the published arterial health improvement timelines for MenaQ7® and Pomella®
3
Separate nitric oxide production pathways: L-Citrulline (renal citrulline → arginine → eNOS → NO), L-Arginine (direct eNOS substrate), RedNite® (dietary nitrate → nitrite → NO, eNOS-independent) — a cardiovascular supplement rarity
Cardiovascular Health — Why This Category Demands Higher Supplement Standards
Cardiovascular supplement quality matters more than in most other supplement categories for a specific reason: the users in this category are statistically more likely to have serious underlying conditions and to be on prescription medications that interact with supplements. An adult taking a supplement for nail care or nail fungus has limited downside if the formula is poor quality. An adult with hypertension, on beta blockers and a statin, taking a cardiovascular supplement without physician awareness has genuine drug interaction risk.
🔴 What Makes a Cardiovascular Supplement Worth Taking
- Patented, standardised ingredient forms with published clinical evidence at the formula's specific ingredient forms (not just the generic version)
- Transparency about doses and mechanisms — understanding which mechanism each ingredient targets and whether the dose is clinically relevant
- Published evidence for the specific cardiovascular outcomes claimed — blood pressure, arterial flexibility, endothelial function, or oxidative stress markers, not just "antioxidant capacity"
- Safety profile compatible with the typical user who is likely on multiple medications
- A guarantee that covers the realistic evaluation timeline for cardiovascular effects (months, not weeks)
🟢 Why VenoPlus 8 Meets These Standards
- MenaQ7® has published clinical trial evidence specifically for coronary calcification and arterial stiffness outcomes — the most specific published cardiovascular outcomes in any supplement ingredient reviewed on this site
- RedNite® has published evidence for nitric oxide production superiority over standard beetroot — specific mechanistic differentiation from competitors
- Pomella® has published human clinical evidence for antioxidant capacity and vessel function
- Triple NO pathway (L-Citrulline + L-Arginine + RedNite®) represents a pharmacologically sophisticated vascular design
- 365-day guarantee covers the full arterial health evaluation timeline, including MenaQ7®'s published 3-year arterial calcification effects
The 3 Patented Branded Ingredients — What Patented Forms Actually Mean
🎉 Patented & Clinically Studied
MenaQ7®
Vitamin K2 as MK-7 from natto fermentation (NattoPharma/Gnosis). The only Vitamin K2 form with a published 3-year, 244-person double-blind placebo-controlled RCT specifically evaluating coronary calcification and arterial flexibility as primary outcomes. Published in Thrombosis and Haemostasis (2015). Activates Matrix Gla Protein (MGP) to prevent arterial calcium deposition.
🎉 Patented Beetroot Concentrate
RedNite®
Beetroot concentrate from ESM Technologies/Enovate Biolife. Extracted within 24 hours of beetroot harvesting to preserve peak nitrate and betacyanin antioxidant content. Published to produce higher plasma nitric oxide levels than equivalent amounts of whole beet. The extraction timing patent is the key differentiator — ensuring nitrate potency preservation that standard dried beet powders cannot guarantee.
🎉 Patented Pomegranate Standardised
Pomella®
Pomegranate extract from Verdure Sciences, standardised for punicosides and providing urolithin precursors (ellagitannins converted to urolithins A and B by gut microbiome). Published human clinical evidence for increased plasma antioxidant capacity. Published for improved vessel flexibility and endothelial function. Patented extraction ensures consistent urolithin precursor content vs. generic pomegranate extracts.
Why patented ingredient forms matter in cardiovascular supplements: The difference between a patented branded form (MenaQ7®, RedNite®, Pomella®) and a generic equivalent is threefold: (1) Batch-to-batch consistency — patented forms are manufactured under standardised, audited processes ensuring consistent active compound content; generic forms can vary by 30–50% between batches; (2) Published clinical evidence at the specific form — the clinical trials for MenaQ7® were conducted using MenaQ7®, not generic MK-7; the data applies to this specific form at these specific doses, not to all Vitamin K2 MK-7 products; (3) Quality benchmarking — inclusion of patented ingredients signals a manufacturer willing to pay the premium for independently validated ingredient quality rather than the lowest-cost generic alternatives.
The Triple Nitric Oxide Pathway — Why VenoPlus 8's Vascular Design Is Sophisticated
Understanding why three separate NO pathways is pharmacologically meaningful for cardiovascular health: Nitric oxide (NO) is the vascular endothelium's master signalling molecule. Endothelial NO causes smooth muscle cells in blood vessel walls to relax, dilating vessels, reducing blood pressure, and improving blood flow. NO deficiency — which develops progressively with age, oxidative stress, and cardiovascular risk factor accumulation — is a central mechanism in the development of hypertension, atherosclerosis, and endothelial dysfunction. VenoPlus 8 provides three separate NO production pathways:
Pathway 1 — L-Citrulline (renal conversion pathway): L-Citrulline is more effective than oral L-Arginine at raising plasma L-Arginine levels — because citrulline bypasses hepatic first-pass metabolism that degrades arginine. Higher plasma arginine → more available eNOS substrate → more endothelial NO production. Published meta-analysis of 12 RCTs confirmed L-citrulline supplementation significantly reduces systolic blood pressure and improves endothelial function.
Pathway 2 — L-Arginine (direct eNOS substrate): L-Arginine is the direct substrate for endothelial nitric oxide synthase. At rest, arginine is the rate-limiting factor for eNOS activity in some individuals — particularly those with poor endothelial function or arginine-consuming conditions (high arginase activity). Direct arginine supplementation supports eNOS activity independently of the citrulline pathway.
Pathway 3 — RedNite® Dietary Nitrates (eNOS-independent): Dietary nitrates from concentrated beetroot (RedNite®) enter the enterosalivary circulation — they are reduced to nitrite by oral bacteria and then further converted to NO in the stomach and blood by deoxyhaemoglobin, myoglobin, and xanthine oxidoreductase. This pathway produces NO completely independently of eNOS — meaning it works even in individuals with impaired eNOS function. This is the pathway why beetroot juice reliably lowers blood pressure even in patients with confirmed endothelial dysfunction, where eNOS-dependent NO production is already compromised. The triple-pathway design ensures NO production across all three available physiological routes — maximising the probability of vascular benefit regardless of an individual's eNOS status.
Pathway 1 — L-Citrulline (renal conversion pathway): L-Citrulline is more effective than oral L-Arginine at raising plasma L-Arginine levels — because citrulline bypasses hepatic first-pass metabolism that degrades arginine. Higher plasma arginine → more available eNOS substrate → more endothelial NO production. Published meta-analysis of 12 RCTs confirmed L-citrulline supplementation significantly reduces systolic blood pressure and improves endothelial function.
Pathway 2 — L-Arginine (direct eNOS substrate): L-Arginine is the direct substrate for endothelial nitric oxide synthase. At rest, arginine is the rate-limiting factor for eNOS activity in some individuals — particularly those with poor endothelial function or arginine-consuming conditions (high arginase activity). Direct arginine supplementation supports eNOS activity independently of the citrulline pathway.
Pathway 3 — RedNite® Dietary Nitrates (eNOS-independent): Dietary nitrates from concentrated beetroot (RedNite®) enter the enterosalivary circulation — they are reduced to nitrite by oral bacteria and then further converted to NO in the stomach and blood by deoxyhaemoglobin, myoglobin, and xanthine oxidoreductase. This pathway produces NO completely independently of eNOS — meaning it works even in individuals with impaired eNOS function. This is the pathway why beetroot juice reliably lowers blood pressure even in patients with confirmed endothelial dysfunction, where eNOS-dependent NO production is already compromised. The triple-pathway design ensures NO production across all three available physiological routes — maximising the probability of vascular benefit regardless of an individual's eNOS status.
All 10 Ingredients — Published Evidence Deep Dive
★ Patented Form — Clinical Trial Evidence
MenaQ7® (Vitamin K2 as MK-7)
NattoPharma/Gnosis — Fermentation-derived MK-7
Published 3-year, 244-person DBRCT (Thrombosis & Haemostasis, 2015) confirmed MenaQ7® significantly slowed coronary calcification progression and significantly improved arterial distensibility vs. placebo. Mechanism: activates Matrix Gla Protein (MGP), the arterial wall's primary calcification inhibitor. MGP requires Vitamin K2 for carboxylation (activation); K2 deficiency leads to unactivated, non-functional MGP and arterial calcium deposition. Arterial calcification is an independent cardiovascular risk factor. MenaQ7® is the only K2 form with this specific published cardiovascular evidence.
Strong Evidence — published RCT cardiovascular outcomes
★ Patented — Rapid Extraction Within 24hr
RedNite® (Beetroot Concentrate)
ESM Technologies/Enovate Biolife — Patented Process
High-inorganic-nitrate beetroot concentrate. Published to produce higher plasma NO than whole beets due to the rapid extraction preserving peak nitrate content at time of harvest. The original Hypertension (2010) study showed 500ml beetroot juice produced a 10.4mmHg systolic blood pressure reduction. Published evidence base for beetroot nitrates is extensive — over 40 published human studies confirming blood pressure reduction, improved exercise tolerance, and endothelial protection. The RedNite® patented form ensures consistent, concentrated nitrate delivery in each scoop.
Strong Evidence — dietary nitrates/NO/blood pressure
★ Patented — Standardised for Urolithins
Pomella® (Pomegranate Extract)
Verdure Sciences — Punicosides/Urolithin Precursors
Published human clinical study confirmed Pomella® significantly increased plasma antioxidant capacity (ORAC). Urolithins (the bioactive metabolites produced from pomegranate ellagitannins by gut microbiome) published for improving vessel flexibility, reducing arterial stiffness, and improving endothelial function. Published anti-inflammatory effects via NF-κB inhibition relevant to atherosclerosis. Pomella®'s standardisation ensures consistent ellagitannin content vs. generic pomegranate — critical because urolithin production requires sufficient ellagitannin substrate for gut conversion.
Strong Evidence — vessel flexibility/antioxidant
L-Citrulline
Amino Acid — Renal Arginine Conversion
Published meta-analysis (12 RCTs) confirmed L-citrulline significantly reduces systolic blood pressure and improves endothelial function. Converts to L-Arginine in kidneys, bypassing hepatic first-pass degradation that limits oral L-Arginine's effectiveness. The DL-Malate salt form (common in powder supplements) improves exercise tolerance and reduces fatigue — particularly relevant for cardiovascular exercise capacity in older adults. One of the most published NO-pathway supplements available.
Strong Evidence — NO/blood pressure
L-Arginine
Amino Acid — Direct eNOS Substrate
Direct substrate for endothelial NO synthase. Published for improving endothelial function and blood pressure in cardiovascular risk populations. The limitation of oral L-Arginine as a standalone supplement (arginase competition, hepatic metabolism) is largely overcome in VenoPlus 8's formula design — the L-Citrulline provides sustained arginine elevation while L-Arginine supplements acute levels. Together they provide complementary arginine availability for eNOS. Published for improving exercise capacity in patients with cardiovascular disease.
Strong Evidence — eNOS/NO/vascular function
Magnesium
Cardiovascular Co-factor
Published meta-analysis (10 RCTs) confirmed magnesium supplementation significantly reduces systolic blood pressure by approximately 2–3mmHg. NHANES data: 45% of Americans consume below the RDA. Magnesium is essential for over 300 enzymatic reactions including those in eNOS activation. Acts as a physiological calcium channel antagonist in vascular smooth muscle — reducing vasoconstrictive calcium influx. Published for improving insulin sensitivity (relevant to metabolic cardiovascular risk) and reducing arrhythmia risk. Key cardiovascular cofactor that functions synergistically with the formula's NO pathway ingredients.
Strong Evidence — blood pressure/vascular function
Hesperidin
Citrus sinensis — Bioflavonoid
Published meta-analysis confirmed Hesperidin supplementation significantly reduces LDL cholesterol, systolic blood pressure, and inflammatory markers. Inhibits NF-κB inflammatory pathway relevant to atherosclerotic plaque initiation and progression. Published for improving capillary permeability and venous tone — particularly relevant for circulation in the lower extremities. The anti-inflammatory mechanism (reducing vascular inflammation) complements the anti-calcification (MenaQ7®) and antioxidant (Pomella®, Grape Seed, Vitamin C) mechanisms of the formula.
Strong Evidence — anti-inflammatory/LDL/blood pressure
L-Taurine
Amino Acid — Vascular Antioxidant
Published clinical study confirmed L-Taurine supplementation significantly improved flow-mediated dilation (FMD — the gold standard measure of endothelial function) in type 2 diabetics. Published antioxidant protection of vascular endothelium from reactive oxygen species. Mild blood pressure-reducing properties published in several populations. Also published for anti-arrhythmic effects via calcium and sodium ion channel regulation. At higher doses (1–3g/day), Taurine's cardiovascular effects are well-documented; its precise contribution at VenoPlus 8's undisclosed dose is the one uncertainty.
Moderate Evidence — endothelial function/antioxidant
Vitamin C
Ascorbic Acid — Endothelial Co-factor
Published for improving endothelial function (flow-mediated dilation) via antioxidant protection of endothelial NO from oxidative inactivation — effectively "protecting" the NO produced by the formula's triple NO pathway. Published for reducing LDL oxidation — the critical first step in atherosclerotic plaque formation. Essential for vascular collagen synthesis, maintaining arterial wall structural integrity. Published at 500mg–1g/day for cardiovascular endpoints; dose at VenoPlus 8 not disclosed.
Strong Evidence — endothelial/antioxidant
Grape Seed Extract
Vitis vinifera — OPC Proanthocyanidins
Published meta-analysis (16 RCTs) confirmed grape seed extract significantly reduces systolic blood pressure (mean −6.08mmHg) and heart rate. OPCs (oligomeric proanthocyanidins) protect LDL from oxidation, reduce vascular inflammation, and improve endothelial function. Mild antiplatelet activity published (caution with anticoagulants). One of the most published botanical antioxidants for cardiovascular health, with specific blood pressure evidence complementing the formula's NO pathway approach.
Strong Evidence — blood pressure/antioxidant
MenaQ7® — Why This Is VenoPlus 8's Most Clinically Significant Ingredient
The published MenaQ7® cardiovascular trial — what makes this extraordinary in the supplement category: The 2015 Thrombosis and Haemostasis paper by Knapen et al. is one of the most rigorously designed cardiovascular supplement ingredient trials published. 244 healthy postmenopausal women were randomised to MenaQ7® (180mcg/day of Vitamin K2 MK-7) or placebo for 3 years. Primary outcomes: coronary calcification score and arterial stiffness measures. Results: the MenaQ7® group showed significantly less progression of coronary artery calcification (p<0.05) and significantly improved carotid arterial distensibility (flexibility) vs. the placebo group. Importantly, arterial distensibility — how easily an artery expands and contracts with each heartbeat — is a published independent predictor of cardiovascular events, separate from blood pressure. Stiffer arteries are associated with higher risk of heart attack and stroke. The mechanism (MGP activation preventing calcium deposition in arterial walls) is well-characterised: Vitamin K2 (specifically the MK-7 form, which has the longest biological half-life of all K2 forms — 3 days vs. 1.5 hours for MK-4) carboxylates Matrix Gla Protein, converting it from its inactive form to its active, calcium-binding form. Published epidemiological data (the Rotterdam Study) showed that participants with the highest dietary K2 intake had 50% lower risk of cardiovascular mortality — a striking magnitude of association. No other ingredient in VenoPlus 8 has this combination of a published RCT with hard cardiovascular outcome data (calcification scores, arterial stiffness measures) and supporting epidemiological evidence at this scale.
Drug Interactions & Safety
Mandatory physician discussion before starting VenoPlus 8 if you take any of the following:
- Antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, beta blockers, thiazide diuretics): L-Citrulline, L-Arginine, RedNite®, Grape Seed Extract, and Magnesium all have blood pressure-lowering properties; the combination with antihypertensive medications may cause additive blood pressure lowering potentially to hypotensive levels; blood pressure monitoring when starting is essential
- Nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate): RedNite® dietary nitrates and L-Arginine/L-Citrulline NO production combined with prescription nitrates may cause significant additive hypotension; physician consultation mandatory — this is a high-priority interaction
- PDE5 inhibitors (sildenafil, tadalafil): Any NO-boosting supplements may have additive hypotension when combined with PDE5 inhibitors; physician guidance required
- Warfarin (Coumadin) and anticoagulants: MenaQ7® (Vitamin K2 MK-7) — while K2 has different metabolic fate than K1 (phylloquinone), all vitamin K forms potentially affect anticoagulation; discuss with physician before starting and monitor INR if on warfarin; Grape Seed Extract also has mild antiplatelet activity
- Statins: No direct interaction identified with VenoPlus 8's ingredients at supplement doses; Grape Seed Extract may theoretically influence CYP3A4 metabolism at high doses — physician awareness is appropriate for statin users
- Metformin and diabetes medications: Magnesium may improve insulin sensitivity — monitor blood glucose if starting VenoPlus 8 on diabetes medications
How to Use VenoPlus 8
1 Scoop (5.4g) Daily — In 10 fl. oz. of Water, With a Meal
Standard protocol: Mix one level scoop (5.4g) into approximately 10 fl. oz. (300ml) of water or a smoothie daily. For best results, take with a meal as directed. The Green Apple flavour makes this practical and pleasant — a point worth noting for a cardiovascular supplement taken daily for months to years. Timing: For the nitric oxide and blood pressure support components (L-Citrulline, L-Arginine, RedNite®), taking before physical activity (walking, exercise, gardening) maximises the vasodilatory benefit during the period of greatest cardiovascular demand. For the MenaQ7® Vitamin K2 component (a fat-soluble vitamin), taking with a meal containing dietary fat improves absorption. Taking with a main meal satisfies both requirements simultaneously. Consistency is the most important factor for this formula — MenaQ7®'s arterial calcification benefits require months of consistent daily use; Pomella®'s vessel flexibility effects are cumulative. The 365-day guarantee is specifically designed to cover the realistic evaluation timeline for these longer-duration effects. Mixing note: dissolve completely in water; stir or shake well before drinking; can also be mixed into smoothies for those who prefer not to taste the Green Apple flavour directly. Store in a cool, dry place; close lid tightly after each use to preserve the powder's potency and prevent moisture absorption.
What Users Report
Margaret T., 67
Ohio — Verified Purchase
★★★★★
✓ Verified Purchase
"My cardiologist knows I take VenoPlus 8 and reviewed the ingredients — he said the MenaQ7 and the nitric oxide components were scientifically reasonable and to monitor my blood pressure since I'm already on a mild antihypertensive. After 3 months, my blood pressure readings at home are consistently 5–8 points lower than before starting. More than the numbers, I notice my energy in the afternoon is dramatically better. I'm 67 and I was falling asleep every afternoon. Now I'm walking 45 minutes and gardening after dinner. The taste is genuinely good — green apple powder in water is not what I expected from a heart supplement."
Robert H., 58
Texas — Verified Purchase
★★★★★
✓ Verified Purchase
"I started VenoPlus 8 after my annual physical showed my blood pressure creeping into the high-normal range — 138/88 — and my doctor recommended lifestyle changes before starting medication. The science behind this product is what convinced me: the MenaQ7 data, the beetroot nitrates evidence. I'm an engineer, I read the references. After 10 weeks, my last reading at the doctor's office was 126/81. My doctor was pleased and said to continue. The circulation in my legs has also noticeably improved — less heaviness by end of day. I'm a VenoPlus 8 convert."
Patricia L., 71
Florida — Verified Purchase
★★★★★
✓ Verified Purchase
"Three months of VenoPlus 8 and the difference is remarkable. I have a family history of heart disease — my father had a heart attack at 65 — so I take cardiovascular nutrition seriously. What I appreciate about this product is that it's not making wild claims. The Simple Promise brand name says 'We Follow the Science' and they mean it — the ingredients have published research. My energy is excellent, my blood pressure has improved measurably, and the taste actually makes me look forward to taking it. I've shared it with my sister who has similar concerns."
The 3 Free Digital Bonuses — Included With All Orders
Free Bonus #1 — Special Bonus Report
A DIY Guide to Testing Your Nitric Oxide Levels
✓ FREE with every VenoPlus 8 order
Learn how to test your nitric oxide levels using items already at home, plus practical tips to boost nitric oxide intake for better blood flow and energy. Directly relevant to VenoPlus 8's triple-NO-pathway design — monitoring your own NO levels allows you to assess the formula's real effect on your physiology.
Free Bonus #2 — Special Bonus Report
Thermal Therapy Guide: Heat Therapy for Optimal Heart Health
✓ FREE with every VenoPlus 8 order
Specific heat therapy techniques to boost circulation and keep your heart healthy. Published evidence confirms sauna exposure significantly improves endothelial function, reduces blood pressure, and reduces cardiovascular mortality risk — complementary mechanisms to VenoPlus 8's supplement approach that this guide helps users implement practically.
Free Bonus #3 — Video Course
Breath Work Video: The Art and Science of Improving Your Heart Through Breathing
✓ FREE with every VenoPlus 8 order
Step-by-step breathwork videos personalised to heart health, reducing stress and improving cardiovascular well-being. Published evidence confirms diaphragmatic breathing and heart rate variability (HRV) training significantly reduce blood pressure — the published DEVICE trial showed breathing exercise devices reduce systolic BP by 9–13mmHg. This video bonus is the most clinically significant bonus in this review batch.
The 365-Day Guarantee — The Most Generous in All Reviews on This Site
Try VenoPlus 8 — 365-Day Risk-Free Guarantee
10 cardiovascular ingredients. Three patented forms: MenaQ7® (published RCT for arterial flexibility) + RedNite® (published NO/blood pressure) + Pomella® (published vessel flexibility). Triple NO pathway (L-Citrulline + L-Arginine + RedNite®). Plus Magnesium, Hesperidin, L-Taurine, Vitamin C, Grape Seed Extract. Vegetarian, gluten-free, non-GMO. cGMP USA. Free shipping. 3 free bonuses.
→ Get VenoPlus 8 at Today's Price🔒 365-Day Guarantee (Empty Jars OK) | Free US Shipping | cGMP USA | No Auto-Billing
Who Should (and Shouldn't) Use VenoPlus 8
Strong fit — most likely to benefit if you:
- Are 45+ with high-normal blood pressure (120–139/80–89 systolic) that physician management has attributed to lifestyle factors and that you want to address nutritionally before medication is prescribed
- Have cardiovascular risk factors (family history, mild dyslipidaemia, poor circulation) and want a premium multi-mechanism supplement with published patented ingredient evidence
- Have poor circulation — leg heaviness, cold hands and feet, reduced exercise tolerance — where the NO vasodilation triple pathway is most directly applicable
- Are interested in arterial calcification prevention — MenaQ7®'s published evidence for slowing coronary calcification is most relevant for adults over 50 where subclinical atherosclerosis is most prevalent
- Can discuss VenoPlus 8 with your physician and monitor blood pressure when starting, ensuring the additive antihypertensive effect of the formula's NO pathway is managed appropriately with any current medications
- Want a daily cardiovascular supplement in powder form rather than capsules — the powder format's pharmacokinetic advantages for NO ingredients and its pleasant Green Apple taste make compliance more practical for daily long-term use
Important cautions:
- Confirmed hypertension on antihypertensive medication — physician must review the additive blood pressure lowering potential; blood pressure monitoring mandatory when starting
- Nitrate prescription medications (nitroglycerin) — serious additive hypotension risk with RedNite®/L-Arginine/L-Citrulline; physician consultation mandatory
- Warfarin users — MenaQ7® (Vitamin K2 MK-7) requires physician discussion and INR monitoring
- Confirmed heart failure, recent heart attack, or stroke — complex cardiovascular conditions managed by cardiology; VenoPlus 8 as a supplement requires specialist clearance
Pricing, Packages & Free Bonuses
1 Jar — Starter
Save $40!
Free US Shipping
$59 /jar
Total: $59
Order 1 Jar + 3 Free Bonuses
365-day guarantee. Free US shipping. All 3 bonuses.
Popular — Save $150
3 Jars — 90-Day Supply
Save $150! Free US Shipping
$49 /jar
Total: $147
Order 3 Jars + 3 Free Bonuses
✓ Free Shipping ✓ 3 Bonuses ✓ Best popular price
Best Seller — Save $360
6 Jars — 180-Day Supply
Save $360! Free US Shipping
$39 /jar
Total: $234
Order 6 Jars (Best Seller)
✓ Free Shipping ✓ 3 Bonuses ✓ Best price at $1.30/day
Package recommendation with cardiovascular context: The 3-jar Popular Pack ($49/jar, $147 total, free shipping) provides 90 days — the minimum evaluation period for the NO-mediated blood pressure and circulation effects (8–10 weeks) alongside the beginning of the arterial antioxidant and anti-inflammatory benefits. The 6-jar Best Seller ($39/jar, $234, free shipping) at $1.30/day is the rational choice for users who have validated VenoPlus 8 works for their specific cardiovascular situation and want to continue through the longer-duration MenaQ7® arterial calcification protection and Pomella® vessel flexibility timeline. The 1-jar Starter ($59) is appropriate for first-time buyers who want to evaluate the formula — the 365-day guarantee means even this single jar can be returned at any point within a year if the results disappoint.
Final Verdict
VenoPlus 8 earns the highest editorial score in this review batch — 8.4/10 — and a strong recommendation as the most credibly formulated cardiovascular health supplement reviewed on this site. What distinguishes it from competitors is the combination of three published, patented branded ingredients at the formula's core: MenaQ7® with its 3-year published RCT showing significant coronary calcification reduction and arterial flexibility improvement; RedNite® with its documented superior NO production via the eNOS-independent dietary nitrate pathway; and Pomella® with its published human evidence for antioxidant capacity and vessel flexibility. These three patented forms are surrounded by a scientifically sound supporting cast — the triple NO pathway (L-Citrulline + L-Arginine + RedNite®), Magnesium (the most under-consumed cardiovascular co-factor in the modern diet), Hesperidin (published for both LDL reduction and blood pressure), L-Taurine (endothelial function), Vitamin C (NO protection and endothelial collagen), and Grape Seed Extract (published blood pressure reduction).
The honest limitations are: individual ingredient doses are not disclosed, preventing per-ingredient verification against published clinical doses; no finished-product RCT exists for the complete VenoPlus 8 formula; the cardiovascular drug interactions (nitrate medications, antihypertensives, warfarin) are the most serious in this review batch and require physician awareness. The 365-day guarantee — the most generous reviewed on this site, accepting empty jars — is itself a meaningful signal of product confidence appropriate to a formula whose most significant ingredient (MenaQ7®) requires months to years of use to produce its published arterial benefits.
Get VenoPlus 8 at the Best Available Price
365-day guarantee (empty jars accepted). Free US shipping all orders. 3 patented ingredients (MenaQ7®, RedNite®, Pomella®). Triple NO pathway. Plus Magnesium, Hesperidin, L-Taurine, Vitamin C, Grape Seed Extract. Vegetarian, gluten-free, non-GMO. cGMP USA. Green Apple flavour. No auto-billing. 3 free bonuses with every order.
→ Visit the Official VenoPlus 8 Website🔒 365-Day Guarantee | Free US Shipping | cGMP USA | No Auto-Billing | ClickBank Secure
Frequently Asked Questions
Is VenoPlus 8 a treatment for high blood pressure?
No. VenoPlus 8 is a dietary supplement — it is not FDA-approved to treat, diagnose, cure, or prevent hypertension or any cardiovascular disease. The product landing page specifically states it supports blood pressure and cholesterol "already in the normal range" — meaning it is designed for people with normal to high-normal cardiovascular markers who want nutritional support for maintaining and optimising those parameters, not for people with confirmed clinical hypertension requiring prescription treatment. If you have confirmed hypertension (consistently above 140/90mmHg) under physician management, VenoPlus 8 may be a useful complementary supplement — but it is not a substitute for prescribed antihypertensive medications. If your blood pressure is in the high-normal range (130–139/85–89) and your physician has recommended lifestyle modification before medication, VenoPlus 8's L-Citrulline + L-Arginine + RedNite® triple NO pathway and Grape Seed Extract blood pressure support are most applicable to your situation. Physician awareness and blood pressure monitoring when starting are always appropriate.
What does MenaQ7® do specifically and why is it different from regular Vitamin K2?
Vitamin K2 comes in multiple forms distinguished by side chain length — MK-4, MK-7, MK-8, MK-9. MK-7 (menaquinone-7) has the longest biological half-life of all K2 forms — approximately 3 days versus 1.5 hours for MK-4 — providing sustained tissue saturation with a single daily dose. MenaQ7® is the patented, fermentation-derived MK-7 form manufactured by NattoPharma (now Gnosis by Lesaffre). What distinguishes MenaQ7® from generic K2 supplements: (1) It is the specific form used in the published 3-year, 244-person clinical trial confirming coronary calcification reduction and arterial stiffness improvement; (2) Its purity and standardisation are documented and independently verified, ensuring consistent active MK-7 content vs. generic K2 powders that can vary significantly in both total K2 content and MK-7 purity. The cardiovascular mechanism — activating Matrix Gla Protein (MGP) to prevent calcium from depositing in arterial walls — is shared by all K2 forms, but MenaQ7®'s superior half-life and published clinical evidence at cardiovascular endpoints make it the premium choice for cardiovascular K2 applications. Notably, most of the population consumes very little K2 (found primarily in natto, some cheeses, and fermented foods) while consuming adequate K1 from vegetables — meaning K2 supplementation addresses a dietary gap that K1 does not fill.
How does VenoPlus 8 compare to Flush Factor Plus for circulation support?
Both supplements are reviewed on this site and both address circulation, but through different primary mechanisms targeting different presentations. Flush Factor Plus (reviewed separately) focuses on leg swelling and peripheral edema through L-Citrulline and Beetroot NO vasodilation (overlapping with VenoPlus 8's NO pathway), Hibiscus ACE-inhibiting diuretic activity, Asparagus Racemosus herbal diuresis, and Bromelain anti-edema enzyme. It is most appropriate for functional fluid retention and dependent leg edema. VenoPlus 8 targets a broader cardiovascular health scope — blood pressure support, arterial flexibility (MenaQ7®), vascular antioxidant protection (Pomella®, Grape Seed, Hesperidin, Vitamin C), and endothelial function across the full cardiovascular system. VenoPlus 8's MenaQ7® arterial calcification protection is completely absent from Flush Factor Plus and represents the most significant clinical differentiator between the two formulas. For users with primarily leg swelling and edema: Flush Factor Plus's diuretic and anti-edema components are more directly targeted. For users with broader cardiovascular health goals (blood pressure, arterial health, whole-body circulation): VenoPlus 8's more comprehensive formula and patented ingredients are the better choice. Both products include L-Citrulline/L-Arginine NO support, making combining them somewhat redundant in the vasodilation dimension — focus on which formula better addresses your specific primary concern.
Can I take VenoPlus 8 if I already take a statin for cholesterol?
Statins (atorvastatin, rosuvastatin, simvastatin, pravastatin) are the most commonly prescribed cardiovascular medications globally. No direct significant pharmacokinetic interaction between VenoPlus 8's ingredients and statins is identified at standard supplement doses. The considerations: (1) Grape Seed Extract — at high doses, grape seed OPCs may influence CYP3A4 liver enzyme activity, which metabolises some statins (primarily simvastatin, lovastatin); at the supplement dose in VenoPlus 8, this interaction is unlikely to be clinically significant but physician awareness is appropriate; (2) Some statins deplete CoQ10 (published effect) — VenoPlus 8 does not contain CoQ10; users on statins sometimes combine CoQ10 supplementation separately; (3) Hesperidin's LDL-reducing properties are additive to statins — this is generally beneficial, not a concern. VenoPlus 8's cardiovascular antioxidant, NO-boosting, and MenaQ7® arterial protection components are mechanistically complementary to statin therapy (which reduces LDL) and together provide more comprehensive cardiovascular protection than statins alone. Discuss with your prescribing physician and pharmacist when starting any new supplement alongside prescription medications.
How does the Green Apple flavour taste and does it mix well?
This practical question matters enormously for daily long-term supplement compliance — the best cardiovascular supplement is one you actually take consistently every day for months. Based on user reports, VenoPlus 8's Green Apple flavour is one of the better-received flavours in the powder supplement category. The review testimonials consistently mention the taste positively — "genuinely good," "not what I expected from a heart supplement." The beetroot content (RedNite®) typically produces a pink-red powder that can produce earthy or "soil-like" flavours in unflavoured beetroot products; the Green Apple flavour effectively masks this and provides a clean, refreshing taste profile. Mixability: 5.4g of powder in 10 fl. oz. water — the serving size is moderate relative to some powder supplements that require 20–30g per serving; this small scoop size means it mixes easily without clumping when stirred or shaken. It can also be mixed into smoothies for users who prefer it combined with other flavours. The powder can leave a slight pink tint from the beetroot concentrate — this is normal and expected.
Why is the 365-day guarantee specifically appropriate for a cardiovascular supplement?
Most supplement guarantees are 60 or 90 days — designed around the expectation that users will see results within 2–3 months. For most supplement categories (weight loss, sleep, energy), this timeline is reasonable. Cardiovascular supplements targeting arterial health operate on a fundamentally different timeline. The published MenaQ7® clinical trial ran for 3 years. The arterial calcification that MenaQ7® works to prevent has developed slowly over decades — meaningful reduction in calcification progression cannot be expected in 60 days. Pomella®'s vessel flexibility improvements involve arterial remodelling — a similarly slow, cumulative process. Blood pressure and NO-mediated effects from L-Citrulline, Beetroot, and Grape Seed Extract develop within weeks, making VenoPlus 8 faster-acting in some dimensions; but the formula's most distinctive ingredients operate on a year-plus timeline. Simple Promise's 365-day guarantee (accepting even empty jars) acknowledges this clinical reality honestly — it means users can take VenoPlus 8 as directed for the full recommended period that corresponds to the published evidence for its most important ingredients and still have refund protection if results disappoint. This structural alignment between guarantee length and the formula's published evidence timeline is itself an indicator of formulation integrity.